# Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions

> **NCT01140139** · PHASE1 · COMPLETED · sponsor: **Swedish Institute for Infectious Disease Control** · enrollment: 12 (actual)

## Conditions studied

- HIV-1

## Interventions

- **BIOLOGICAL:** HIV DNA Vaccine

## Key facts

- **NCT ID:** NCT01140139
- **Lead sponsor:** Swedish Institute for Infectious Disease Control
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2010-06-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140139, "Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01140139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*